$Morningstar(MORN)A 40-year "slow company" that was cut in half by the market to $180—yet the founder remains at 38% position and does not move

A Strange Contradiction

In December 2024, Morningstar (NASDAQ: MORN)
$MORN stock price hit a historic high of $354.

By April 17, 2026, when I wrote this article, the stock was at $180.52, a 49% haircut.

Meanwhile, how did its peers perform?

S&P Global (SPGI) fell 7%, Moody’s (MCO) rose 3%, MSCI increased 1.5%. Only FactSet (FDS) plunged 47% along with Morningstar.

In other words, the entire “financial data and ratings” high-margin moat track that Buffett’s family has loved for 30 years, only two companies have been thrown into the trash in the past year.

If you stop at this level, the conclusion is simple: The market’s valuation of “AI disruption anxiety” combined with PitchBook’s slowing growth has punished Morningstar as a growth stock.

But I want to show you something even stranger.

While the market was frantically selling off:

Founder Joe Mansueto held 37–38% of shares and didn’t sell a single share of his main position (the planned 210k-share reduction accounted for only 1.4% of his total holdings, and he executed it steadily within the $160 range).

New CFO Michael Holt bought 1,000 shares on March 4, 2026, at $186.59 on the open market with his own money.

The company repurchased $787 million worth of stock in 2025 at an average price of $240 , and in October 2025 authorized a new three-year $$10 buyback plan—when the stock price had already fallen near $$180 , this $$10 plan had not yet been executed.

In his 2025 shareholder letter, Mansueto personally wrote: “painful to see the decline, but also created an opportunity to increase our ownership in a business that we know as well as any.”

In other words: The market is selling at $180 , insiders are buying at $180 , and the founder is telling shareholders in a letter, “This is a good opportunity to add.”

Such divergence is rare. Rare divergences often mean that at least one side—market or insiders—is making a big mistake.

The conclusion upfront:

This is a “growth downgrade” crisis, not a “business model collapse” crisis. The market has priced the former as the latter.

From a 5-year perspective, MORN’s intrinsic value range is $260–$285, with an optimistic scenario of $380–$415, and downside protection at $150–$160. The asymmetric odds are roughly 1:3 to 1:9.

I will try to lay out all the reasoning in this lengthy article—so you can judge for yourself, rather than blindly follow.

First, a quick intro: What exactly does Morningstar do?

Many people have heard of “Morningstar ratings,” those stars in the top right corner of funds. But equating Morningstar solely with “fund rating website” underestimates the first layer of bias about this company.

Founded in 1984 by Joe Mansueto in his Chicago apartment with $80k, after 40 years, it is now the only independent financial data and research group worldwide that spans six niche segments:

First segment: public market data and terminals. Its flagship product Morningstar Direct is the daily workbench for fund companies, investment advisors, and institutional researchers, covering 300k fund shares, 28k ETFs, and 40k stocks. This business had an adjusted profit margin of 45.1% in 2024.

Second segment: private market data PitchBook. Acquired in 2016 for $225 million. Today, PitchBook covers 10.1 million private companies, 2.9 million deals, and 600k investors. It’s a standard tool for PE/VC due diligence and comparable valuation. In 2025, revenue was about $660 million—nearly 10 times the $225 million invested.

Third segment: credit rating agency DBRS. Acquired in 2019 for $669 million. Now the fourth-largest rating agency in the US, with over 30% market share in commercial mortgage-backed securities (CMBS). Q4 2025 revenue grew 27.9% YoY, the fastest growth engine of the entire company.

Fourth segment: ESG research Sustainalytics. Fully acquired in 2020. After ESG hype faded, this segment experienced two rounds of layoffs, but the data assets’ scarcity in the AI era is underestimated.

Fifth segment: index business Morningstar Indexes. Acquired in February 2026 for $365 million from the University of Chicago’s CRSP—the benchmark provider for flagship index funds like Vanguard VTI and VTSAX. This acquisition pushed Morningstar Indexes’ assets under management beyond $4.2 trillion.

Sixth segment: retirement services Morningstar Retirement. Provides managed account services to over 2 million 401(k) participants, charging based on assets under management, with a 2024 adjusted profit margin of 51.6%.

Putting these six segments together, Morningstar is a hybrid company with subscription (70.3%) + trading (15.7%) + asset-linked (14%) business models. In 2025, total revenue was $210k (+7.5%), adjusted operating profit $583 million (+18%), free cash flow $443 million.

Compare that to S&P Global (SPGI) with $15.3 billion revenue, Moody’s (MCO) with $7.7 billion, MSCI with $3.1 billion. Morningstar’s scale at around $2.4 billion is considered “small to medium” in this circle. But it’s the only independent player that has entered all four legs: private data, credit ratings, ESG, and indexes.

Why did this company get halved? What is the market anxious about?

The worries boil down to three main points.

First: PitchBook’s growth is slowing. In Q1 2024, revenue growth was 11.1%, but by Q4 2025, it dropped to 6.2%. This was Morningstar’s star business for the past five years, suddenly decelerating. The market logic: “PE/VC industry shrinking, product cycle peaking, and competition intensifying after Blackstone’s acquisition of Preqin.”

Second: AI anxiety. The market fears: Will ChatGPT, Perplexity, Bloomberg GPT overthrow Morningstar and FactSet’s “seat-based” data terminals within three years? The 47% haircut of FDS is already pricing this risk in, dragging MORN down with it.

Third: High base effect in 2026. In 2024, the spin-off of TAMP business to AssetMark contributed a one-time gain of $64 million. Starting Q1 2026, quarterly reports will face “less attractive YoY comparisons,” and conservative modeling by institutions will suppress valuation.

Each worry is real. But each is a “growth downgrade,” not a “business model collapse.”

PitchBook’s logic is simple—it’s not losing clients but losing high-speed growth. Net retention rate (NRR) dropped from 114% in 2023 to 107% in 2024, still healthy. Licenses in Q3 2024 increased YoY by 19%. The real question: after serving top PE funds, top investment banks, and top law firms, where is the next growth coming from? The answer: product TAM expanding from “core PE/VC clients” to “wealth management, private credit, family offices”—this takes time but is not a business death.

The counterexample to AI anxiety: The hotter the LLM, the more valuable PitchBook data becomes. Anthropic Claude, OpenAI ChatGPT, Perplexity, Rogo, Hebbia—all are paying to access PitchBook data via MCP protocols—because private company info can’t be crawled or fabricated by LLMs. This is entirely different from public market data (which AI can aggregate itself). Similarly, DBRS’s rating data has legal authority, and Sustainalytics’s ESG scores are regulatory compliance essentials—these are “licensed / compliant / exclusive” data assets, which are the most valuable parts in the AI era.

High base effect worries are the least meaningful. The market always discounts companies with no growth based on TTM data, then overhypes them after exceeding expectations. This is emotional pricing, not fundamentals.

But the most crucial evidence in this article—management

If I had to pick one reason to buy MORN at $180 , it would be “management.”

Joe Mansueto’s shareholding structure and compensation design are the most thorough alignment of interests I’ve seen among US small- and mid-cap shareholders.

Mansueto owns about 14.57 million shares of MORN, accounting for 37–38% of 38.5 million total shares, with a market cap of roughly $2.66 billion—almost his entire net worth.

His 2023 total compensation as Executive Chairman: $105,250. Not a typo—just one hundred five thousand two hundred fifty dollars. Cash salary, plus a few thousand in benefits, zero equity grants.

In other words: All his returns are tied 100% to his 38% stake. No salary, no bonus, no options—if the stock price rises, he profits; if it falls, he loses together.

This compensation structure means: You never need to worry about him doing short-term actions that harm long-term shareholders. You also never need to worry about him manipulating the stock with “performance expectations adjustments”—because for him, long-term market value is the only wealth preservation tool.

As for the 212k shares he plans to reduce via a 10b5-1 pre-arranged plan from August 2025 to March 2026 (cash-out about $420–$192837465657483.91T)—there are two key points:

First, this plan was set in November 2024 when the stock was around $E2@, and he cannot cancel it arbitrarily;

Second, this reduction only accounts for 1.4% of his total holdings, and he continued to sell within the $155–$180 range as planned. If he truly believed the company’s fundamentals were collapsing, he wouldn’t let himself be forced to sell at half-peak—he would just cancel the plan. The real purpose of this reduction is for GRAT trust annuity payments and estate tax planning, unrelated to his confidence in the company.

Looking at CEO Kunal Kapoor: Born in 1975, of Indian descent, CFA charterholder, joined Morningstar as a data analyst in 1997—not the usual story of 2000. He’s been with the company for 20 years, serving as Director of Fund Research, founding team of Morningstar Investment Services, International Business Strategy Director, Global Data Head, President, and took over as CEO in 2017.

His three most important capital allocation decisions:

PitchBook acquisition—A+. Paid $225 million in 2016. Today, PitchBook alone is valued at about $8 billion, based on Blackstone’s 2024 $192837465657483.91T valuation of Preqin (13x revenue), implying an approximate value of $8 billion. A $80k investment, nearly 35x return over 10 years.

DBRS acquisition—A. Paid $669 million in 2019. In 2025, credit revenue was about $355 million, still accelerating. The core assets have mostly recovered principal, with the rest compounding.

CRSP acquisition—B+. In February 2026, bought Chicago’s CRSP for $365 million, mainly to secure benchmark contracts for trillion-dollar index funds like Vanguard VTI/VTSAX. This gave Morningstar Indexes an asset-based fee curve, similar to MSCI.

What impresses me most is that Morningstar’s compensation committee truly punishes CEOs.

In May 2022, Kapoor’s MSU equity incentive was granted, with a 3-year TSR linkage—only 82.0% vested; in November 2022, only 28.8%. In 2025, Kapoor could earn 115.5% of his annual bonus, but the compensation committee actively reduced it to 111.4% due to “a small number of delayed product deliveries.”—just because a few products were late.

In the US stock CEO ecosystem, where bonuses are often fully paid regardless of performance, this “real penalty” mechanism is rare. It shows two things: one, the board’s independence is genuine; two, the company takes “commitment—delivery—fulfillment” seriously.

One last detail—new CFO Michael Holt: He took over in January 2025, with 17 years at Morningstar since 2008. On March 4, 2026, he bought 1,000 shares at $186.59 on the open market with his own money, currently holding 9,480 shares.

A new CFO buying stock near the current price with personal funds is very rare among US small caps—open market purchases (not options exercises or limit-and-hold) are a strong signal that “I believe the current price is below intrinsic value, and I am willing to put my own money on this judgment.”

Valuation: 14 methods cross-validated—what’s a reasonable price?

I used 14 valuation methods across four categories for cross-checking, all figures here for your reference.

Sum-of-the-parts (SOTP) is the most relevant—because the company’s six business lines have completely different valuation logic. Conservative assumptions: PitchBook at 5x revenue, DBRS at Moody’s 14x EBITDA, Direct Platform at FactSet multiples, Indexes at MSCI multiples, summing to an intrinsic value of about $307 per share. Neutral assumptions: PitchBook at 9x revenue—$384. Optimistic assumptions: PitchBook at 13x revenue (like Preqin)—$415.

DCF realistic scenario: 2026–2030 FCF growth 9–10%, WACC 9%, perpetual growth 2.75%, per share value $220.
Pessimistic scenario (FCF growth 5%, WACC 9.5%)—$158—a key anchor, indicating that if Morningstar grows little over five years, this is its fair value.

Buffett-style Owner Earnings: FY2025 net profit $374 million + D&A $190 million – CapEx $147 million – change in working capital, yields $346 million. Divided by 42 million diluted shares, about $8.20 per share, multiplied by 18–25x reasonable multiple—$147–$205.

EV/EBITDA relative valuation: Industry median 19x → $309; conservative use of SPGI’s current 16.5x → $267; Morningstar’s 10-year median 17.3x → $281.

P/E relative valuation: 2026E EPS estimate $11.35, applying 24x (below SPGI, MCO, MSCI) → $272.

Asset replacement cost (Greenwald method): Summing the cost of rebuilding Morningstar’s database, brand, client relationships, and employee capital from scratch—about $224—a hard bottom unlikely to fall below.

Combining all 14 results, the valuation distribution:

The median fair value is about $260, close to the sell-side consensus of $256.5. UBS rates it “Buy,” BMO “Outperform.”

The key attraction of this trade is the asymmetric risk-reward:
Downside 14% (to $155), upside 44% (neutral $260), up to 130% (optimistic $415).
Odds roughly 1:3 to 1:9.

Catalysts and risks—I won’t hide them

Catalysts, ordered by probability:

• Short-term: Q1 2026 earnings on April 29 will verify if PitchBook stabilizes;
  The $$280 buyback over three years, if executed vigorously within the $180 range, could reduce share count by 14%;
  The Fed’s continued rate cuts in 2026 could sustain 25%+ high growth in DBRS credit ratings.

• Mid-term: CRSP integration completes, and Indexes start generating asset-based fee growth;
  If PitchBook resumes double-digit growth in late 2026, market sentiment will quickly recover;
  Morningstar Wealth turns profitable.

• Long-term: Mansueto, age 69, will have a clear succession plan in 3–5 years, reducing “founder retirement uncertainty” discount.

Risks are also straightforward.

If PitchBook’s growth permanently stabilizes at 5–8%, my optimistic valuation will need to be lowered to around $$180 ;
If AI truly develops a product within three years that replaces the Direct terminal and gains industry recognition, the seat-based model will be squeezed;
Sustainalytics’s ESG business shows no signs of revival in the short term;
If Mansueto’s governance succession is mishandled (e.g., selling controlling stake to private equity), it could cause short-term liquidity shocks.

I don’t think these risks will break MORN below $150—but they could slow valuation recovery by 12–18 months.

Five-year 10x space? My honest answer

Applying my “hold for 5 years, 10x upside” principle:

• Revenue 10x in 5 years would mean going from 300k to 28k—requiring an annual 58% growth, which is unrealistic.

• Stock price 10x in 5 years would be $1,800—requiring extreme optimism in both valuation multiples and earnings, low probability.

But I believe there’s over 70% chance the stock will be 1.5–2.5x higher in five years (to $270–$450).
If the AI narrative reverses, PitchBook re-accelerates, and CRSP fully monetizes, a 3x (to $540) is also possible.

In other words: MORN isn’t a typical “10x stock” candidate—its business structure doesn’t support that. But it’s a mispriced, downside-protected, compound-quality asset.
Such assets are best viewed as “core holdings in a long-term portfolio, low-volatility anchors,” not “aggressive growth stocks aiming for 10x in five years.”

Frankly, my framework for 10x positions is better suited for beaten-down crypto leaders.
MORN in my stock portfolio plays a different role: a counter-cyclical compound anchor, a rebalancing tool during extreme sentiment, a low-maintenance core for five years.

Conclusion: Patience against emotions

Buffett said in his 1989 shareholder letter: “Time is the friend of good businesses and the enemy of mediocre ones.”

Today, Morningstar is a good business—40 years of mission, no founder change, no accounting fraud, no governance collapse. But it’s experiencing an “emotionally mispriced” correction, as the market’s timing isn’t right.

Wang Yangming said “Unity of knowledge and action.”
The knowledge part: the 14 valuation methods tell you it’s cheap at $175 .
The action part: whether you believe in the founder’s 38% stake, CFO’s buy, and the company’s $$285 buyback—these are judgments from those closer to the information source.

My decision: Build a 3–5% core position.
Add to 5–7% if below $$415 , and to 7–10% if below $$280 .
Hold for 5 years.

I make no promises on results. But I promise: If fundamentals show “PitchBook quarterly growth < 5%”, “NRR drops below 100%”, “CFO/CEO suddenly resigns”, or “management’s large non-mechanical sell-off”—I will tell you immediately, regardless of profit or loss.

This is the essence of “crisis investing and research”—we’re not betting on ups and downs, but on “reversible crises × emotional mispricing × huge potential × patience squared.”

Any factor failing this formula, exit immediately.

⚠: This article is only my personal investment research sharing, not investment advice!

Creating content is hard. If you’re interested in truly “value stocks,” follow me—I will keep sharing the latest research reports for your review!

[#Crisis Investment Model]

![]$193 https://img-cdn.gateio.im/webp-social/moments-1f1ac76a7d-f0c8d391bc-8b7abd-badf29.webp$10